VRDN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.58%

Insider Buying (Last 12 Months): $30,616,312.00

Insider Selling (Last 12 Months): $0.00

Viridian Therapeutics Insider Trading History Chart

Viridian Therapeutics Share Price & Price History

^$13.66

▼ -0.16 (-1.16%)

As of 05/21/2025 05:00 PM ET

Days: 30 | 90 | 365

Viridian Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/27/2024	Stephen F. Mahoney	CEO	Buy	21,400	$23.33	$499,262.00	21,400
9/27/2024	Thomas W Beetham	COO	Buy	5,000	$23.41	$117,050.00	6,000
9/13/2024	Fairmount Funds Management Llc	Director	Buy	1,600,000	$18.75	$30,000,000.00	3,445,813
1/22/2024	Fairmount Funds Management Llc	Director	Buy	476,190	$21.00	$9,999,990.00	1,839,954
6/15/2023	Lara Meisner	Insider	Sell	2,269	$28.02	$63,577.38	29,971
6/5/2023	Lara Meisner	Insider	Sell	499	$25.03	$12,489.97	29,971
6/2/2023	Lara Meisner	Insider	Sell	1,875	$24.21	$45,393.75	29,971
4/12/2023	Scott Dunseth Myers	CEO	Buy	4,000	$25.37	$101,480.00	259,500
3/13/2023	Scott Dunseth Myers	CEO	Buy	5,500	$29.15	$160,325.00	255,500
3/9/2023	Lara Meisner	General Counsel	Sell	29,971	$29.07	$871,256.97
2/2/2023	Jonathan Violin	Insider	Sell	50,000	$36.80	$1,840,000.00	430,905
1/23/2023	Lara Meisner	General Counsel	Sell	6,843	$35.66	$244,021.38
1/17/2023	Barrett Katz	insider	Sell	24,853	$37.21	$924,780.13
1/13/2023	Barrett Katz	insider	Sell	4,147	$37.01	$153,480.47
1/10/2023	Barrett Katz	insider	Sell	47,377	$35.30	$1,672,408.10
12/20/2022	Lara Meisner	General Counsel	Sell	600	$28.07	$16,842.00
12/16/2022	Lara Meisner	General Counsel	Sell	1,297	$28.44	$36,886.68
12/14/2022	Lara Meisner	General Counsel	Sell	15,656	$28.12	$440,246.72
12/12/2022	Lara Meisner	General Counsel	Sell	600	$28.05	$16,830.00
11/15/2022	Lara Meisner	General Counsel	Sell	8,125	$22.05	$179,156.25
8/17/2022	Fairmount Funds Management Llc	Director	Buy	425,531	$23.50	$9,999,978.50	1,363,764
6/1/2022	Jonathan Violin	Insider	Sell	30,000	$12.20	$366,000.00	480,905

See Full Table

SEC Filings (Institutional Ownership Changes) for Viridian Therapeutics (NASDAQ:VRDN)

Institutional Buying and Selling by Quarter

Viridian Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	130,570	$1.76M	0.0%	+12.8%	0.160%
5/16/2025	Exome Asset Management LLC	217,294	$2.93M	2.5%	N/A	0.266%
5/16/2025	Octagon Capital Advisors LP	450,000	$6.07M	0.6%	-48.3%	0.552%
5/16/2025	Goldman Sachs Group Inc.	1,231,092	$16.60M	0.0%	+33.8%	1.509%
5/16/2025	Yiheng Capital Management L.P.	500,261	$6.74M	0.6%	-33.3%	0.613%
5/16/2025	Parkman Healthcare Partners LLC	1,064,506	$14.35M	1.7%	-2.1%	1.305%
5/16/2025	Millennium Management LLC	297,966	$4.02M	0.0%	-18.6%	0.365%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	49,276	$0.67M	0.0%	+1.8%	0.060%
5/16/2025	Alliancebernstein L.P.	2,021,619	$27.25M	0.0%	-11.6%	2.478%
5/16/2025	Adage Capital Partners GP L.L.C.	1,114,586	$15.03M	0.0%	-33.3%	1.366%
5/16/2025	ADAR1 Capital Management LLC	79,000	$1.07M	0.2%	+203.8%	0.097%
5/15/2025	Maverick Capital Ltd.	2,061,274	$27.79M	0.5%	+0.4%	2.526%
5/15/2025	Paradigm Biocapital Advisors LP	2,095,079	$28.24M	1.3%	+15.1%	2.568%
5/15/2025	Panagora Asset Management Inc.	354,739	$4.78M	0.0%	+40.2%	0.435%
5/15/2025	Yiheng Capital Management L.P.	500,261	$6.74M	0.4%	-33.3%	0.613%
5/15/2025	Driehaus Capital Management LLC	1,270,481	$17.13M	0.2%	-32.3%	1.557%
5/14/2025	Affinity Asset Advisors LLC	390,000	$5.26M	0.5%	+144.3%	0.478%
5/14/2025	Rafferty Asset Management LLC	105,874	$1.43M	0.0%	-38.8%	0.130%
5/14/2025	Candriam S.C.A.	880,430	$11.87M	0.1%	+20.4%	1.079%
5/14/2025	EntryPoint Capital LLC	13,742	$0.19M	0.1%	N/A	0.017%
5/14/2025	Hsbc Holdings PLC	39,452	$0.53M	0.0%	N/A	0.048%
5/14/2025	Quantbot Technologies LP	21,131	$0.29M	0.0%	+146.4%	0.026%
5/14/2025	Wellington Management Group LLP	249,170	$3.36M	0.0%	+11.0%	0.305%
5/13/2025	Northern Trust Corp	702,517	$9.47M	0.0%	+1.2%	0.861%
5/13/2025	Algert Global LLC	45,543	$0.61M	0.0%	-52.8%	0.056%
5/13/2025	Raymond James Financial Inc.	318,240	$4.29M	0.0%	+1.4%	0.390%
5/13/2025	American Century Companies Inc.	122,892	$1.66M	0.0%	+8.2%	0.151%
5/13/2025	Persistent Asset Partners Ltd	37,211	$0.50M	0.4%	+47.4%	0.046%
5/13/2025	Russell Investments Group Ltd.	198,258	$2.67M	0.0%	-47.8%	0.243%
5/12/2025	Knott David M Jr	30,000	$0.40M	0.2%	+20.0%	0.037%
5/12/2025	Nuveen LLC	248,628	$3.35M	0.0%	N/A	0.305%
5/12/2025	Invesco Ltd.	47,771	$0.64M	0.0%	+44.3%	0.059%
5/12/2025	Swiss National Bank	107,500	$1.45M	0.0%	-4.5%	0.132%
5/9/2025	Deutsche Bank AG	396,808	$5.35M	0.0%	-1.5%	0.486%
5/9/2025	Charles Schwab Investment Management Inc.	565,963	$7.63M	0.0%	-1.6%	0.694%
5/9/2025	Vanguard Group Inc.	4,563,100	$61.51M	0.0%	-0.7%	5.593%
5/9/2025	BIT Capital GmbH	71,680	$0.97M	0.1%	-74.9%	0.088%
5/9/2025	DCF Advisers LLC	62,029	$0.84M	0.4%	+108.5%	0.076%
5/9/2025	J. Safra Sarasin Holding AG	72,672	$0.98M	0.0%	+99.4%	0.089%
5/8/2025	XTX Topco Ltd	12,197	$0.16M	0.0%	-46.9%	0.015%
5/7/2025	TD Asset Management Inc	32,600	$0.44M	0.0%	-36.3%	0.040%
5/7/2025	Knights of Columbus Asset Advisors LLC	59,281	$0.80M	0.1%	+2.7%	0.073%
5/2/2025	Victory Capital Management Inc.	552,850	$7.45M	0.0%	+34.7%	0.678%
5/1/2025	Rice Hall James & Associates LLC	362,893	$4.89M	0.3%	+579.9%	0.445%
4/30/2025	Alps Advisors Inc.	61,478	$0.83M	0.0%	-4.0%	0.075%
4/29/2025	Bank of New York Mellon Corp	198,177	$2.67M	0.0%	+0.8%	0.243%
4/29/2025	Moody Aldrich Partners LLC	57,841	$0.78M	0.2%	-1.4%	0.071%
4/28/2025	Principal Financial Group Inc.	208,836	$2.82M	0.0%	+17.0%	0.256%
4/28/2025	Teacher Retirement System of Texas	14,940	$0.20M	0.0%	-12.2%	0.018%
4/25/2025	Amalgamated Bank	2,531	$34K	0.0%	+49.7%	0.003%
4/15/2025	SG Americas Securities LLC	31,972	$0.43M	0.0%	+2.9%	0.039%
4/10/2025	Hennion & Walsh Asset Management Inc.	199,193	$2.69M	0.1%	-5.6%	0.244%
4/8/2025	Rhumbline Advisers	104,559	$1.41M	0.0%	+4.6%	0.128%
4/7/2025	GAMMA Investing LLC	8,425	$0.11M	0.0%	+3,892.9%	0.010%
3/24/2025	Wellington Management Group LLP	224,484	$4.30M	0.0%	-4.9%	0.275%
3/18/2025	California State Teachers Retirement System	54,710	$1.05M	0.0%	+18.0%	0.067%
2/18/2025	Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.	423,272	$8.11M	1.0%	-33.1%	0.534%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	115,782	$2.22M	0.0%	+29.4%	0.146%
2/17/2025	Woodline Partners LP	813,647	$15.60M	0.1%	-0.7%	1.027%
2/17/2025	Soleus Capital Management L.P.	45,500	$0.87M	0.1%	-52.1%	0.057%
2/17/2025	Squarepoint Ops LLC	33,251	$0.64M	0.0%	-23.7%	0.042%
2/17/2025	Two Sigma Advisers LP	335,569	$6.43M	0.0%	-24.6%	0.424%
2/17/2025	Two Sigma Investments LP	424,537	$8.14M	0.0%	-11.9%	0.536%
2/17/2025	Tang Capital Management LLC	2,492,925	$47.79M	3.2%	+11.1%	3.147%
2/17/2025	Rafferty Asset Management LLC	172,960	$3.32M	0.0%	+90.8%	0.218%
2/17/2025	ProShare Advisors LLC	20,584	$0.40M	0.0%	+74.1%	0.026%
2/17/2025	Paradigm Biocapital Advisors LP	1,820,079	$34.89M	1.2%	-37.1%	2.298%
2/17/2025	Parkman Healthcare Partners LLC	1,087,634	$20.85M	2.8%	+155.9%	1.373%
2/17/2025	Nuveen Asset Management LLC	681,012	$13.06M	0.0%	+198.2%	0.860%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	44,600	$0.86M	0.1%	N/A	0.056%
2/17/2025	Millennium Management LLC	365,972	$7.02M	0.0%	-45.2%	0.462%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	48,400	$0.93M	0.0%	+40.7%	0.061%
2/17/2025	Graham Capital Management L.P.	12,900	$0.25M	0.0%	-10.6%	0.016%
2/17/2025	D. E. Shaw & Co. Inc.	442,070	$8.47M	0.0%	+220.2%	0.558%
2/17/2025	Deutsche Bank AG	402,874	$7.72M	0.0%	+6.1%	0.509%
2/17/2025	Driehaus Capital Management LLC	1,875,876	$35.96M	0.3%	-5.8%	2.368%
2/17/2025	Deep Track Capital LP	4,522,741	$86.70M	3.2%	+20.6%	5.710%
2/17/2025	Concentric Capital Strategies LP	88,527	$1.70M	0.1%	N/A	0.112%
2/17/2025	Corton Capital Inc.	12,702	$0.24M	0.1%	-19.6%	0.016%
2/17/2025	Crestline Management LP	200,857	$3.85M	0.1%	+31.7%	0.254%
2/17/2025	Cutter Capital Management LP	628,677	$12.05M	4.9%	+21.2%	0.794%
2/17/2025	Braidwell LP	34,094	$0.65M	0.0%	N/A	0.043%
2/17/2025	Brevan Howard Capital Management LP	13,473	$0.26M	0.0%	N/A	0.017%
2/17/2025	Balyasny Asset Management L.P.	130,721	$2.51M	0.0%	-61.4%	0.165%
2/17/2025	Bayesian Capital Management LP	25,700	$0.49M	0.1%	+99.2%	0.032%
2/17/2025	Bank of America Corp DE	247,107	$4.74M	0.0%	+36.5%	0.312%
2/17/2025	BNP Paribas Financial Markets	203,853	$3.91M	0.0%	N/A	0.257%
2/17/2025	Ameriprise Financial Inc.	48,793	$0.94M	0.0%	+16.2%	0.062%
2/17/2025	Algert Global LLC	96,393	$1.85M	0.0%	-16.1%	0.122%
2/14/2025	Novo Holdings A S	2,250,000	$43.13M	2.6%	-5.7%	2.841%
2/14/2025	Schonfeld Strategic Advisors LLC	670,600	$12.86M	0.1%	-12.1%	0.847%
2/14/2025	Foresite Capital Management VI LLC	1,974	$38K	0.0%	N/A	0.002%
2/14/2025	Northern Trust Corp	694,142	$13.31M	0.0%	+19.3%	0.876%
2/14/2025	The Manufacturers Life Insurance Company	49,720	$0.95M	0.0%	+101.0%	0.063%
2/14/2025	Tudor Investment Corp ET AL	38,367	$0.74M	0.0%	+3.0%	0.048%
2/14/2025	Artia Global Partners LP	100,000	$1.92M	0.7%	N/A	0.126%
2/14/2025	Virtus ETF Advisers LLC	3,952	$76K	0.0%	-43.6%	0.005%
2/14/2025	Nebula Research & Development LLC	17,132	$0.33M	0.0%	N/A	0.022%
2/14/2025	Lord Abbett & CO. LLC	459,588	$8.81M	0.0%	+17.3%	0.580%
2/14/2025	Voya Investment Management LLC	21,397	$0.41M	0.0%	+5.1%	0.027%

Data available starting January 2016

See Full Table

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $13.66

$13.26

$13.85

50 Day Range

MA: $13.25

$11.02

$16.04

52 Week Range

Now: $13.66

$9.90

$27.20

Volume

1,029,191 shs

Average Volume

1,194,417 shs

Market Capitalization

$1.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of Viridian Therapeutics?: Viridian Therapeutics' top insider investors include:
Fairmount Funds Management Llc (Director)
Lara Meisner (Insider)
Stephen F Mahoney (CEO)
Thomas W Beetham (COO)
Learn More about top insider investors at Viridian Therapeutics.
Who are the major institutional investors of Viridian Therapeutics?: Viridian Therapeutics' top institutional shareholders include:
Vanguard Group Inc. — 5.59%
Paradigm Biocapital Advisors LP — 2.57%
Maverick Capital Ltd. — 2.53%
Alliancebernstein L.P. — 2.48%
Driehaus Capital Management LLC — 1.56%
Goldman Sachs Group Inc. — 1.51%
Learn More about top institutional investors of Viridian Therapeutics stock.
Which major investors are selling Viridian Therapeutics stock?: During the last quarter, VRDN stock was sold by these institutional investors:
Driehaus Capital Management LLC
Adage Capital Partners GP L.L.C.
Octagon Capital Advisors LP
Alliancebernstein L.P.
Yiheng Capital Management L.P.
Yiheng Capital Management L.P.
BIT Capital GmbH
Russell Investments Group Ltd.
Which major investors are buying Viridian Therapeutics stock?: Within the previous quarter, VRDN stock was acquired by institutional investors including:
Goldman Sachs Group Inc.
Rice Hall James & Associates LLC
Paradigm Biocapital Advisors LP
Nuveen LLC
Affinity Asset Advisors LLC
Exome Asset Management LLC
Candriam S.C.A.
Victory Capital Management Inc.
In the previous year, these company insiders have bought Viridian Therapeutics stock:
Fairmount Funds Management Llc (Director)
Lara Meisner (Insider)
Stephen F Mahoney (CEO)
Learn More investors buying Viridian Therapeutics stock.